ERBB2 and endometrial cancer: An inverse association has been described between HER2 amplification/overexpression and the presence of receptors for the steroid hormones oestrogen and progesterone in both clinical correlative studies and experimental models for both breast and endometrial cancer (Bigsby et al, 1992; Konecny et al, 2003; Mariani et al, 2005).